Standout Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis 2013 2026 2017 2021 2.0k
  1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis (2013)
    Brian G. Feagan, Paul Rutgeerts et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 12 from Science/Nature 69 standout
Sub-graph 1 of 18

Citing Papers

Navigating the complexities of drug development for inflammatory bowel disease
2024 Standout
Ulcerative Colitis in Adults
2023 Standout
38 intermediate papers

Works of Tim Wyant being referenced

An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
2016
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
and 7 more

Author Peers

Author Last Decade Papers Cites
Tim Wyant 1363 2126 2635 31 3.7k
Maria Rosario 1340 2337 3015 47 3.7k
S. B. Hanauer 790 1537 2066 40 3.1k
Fabian Schnitzler 886 1749 2295 42 2.9k
Omoniyi J. Adedokun 1662 2777 3854 70 4.5k
Freddy Cornillie 1524 1524 2032 79 5.1k
Bruce Salzberg 820 1600 2134 39 2.8k
Masakazu Takazoe 1177 932 1760 74 2.7k
Stephan Targan 699 1510 2068 45 3.0k
Wojciech Niezychowski 668 1197 1787 30 2.5k
Julia Seiderer 1377 697 1299 53 2.8k

All Works

Loading papers...

Rankless by CCL
2026